Bradykinin-target therapies in SARS-CoV-2 infection: current evidence and perspectives Manuele Figueiredo da SilvaJoão Xavier de Araújo-JúniorLucindo José Quintans-Júnior Review 28 January 2022 Pages: 275 - 283
Lipopolysaccharide induced altered signaling pathways in various neurological disorders Sukhdev SinghKuleshwar SahuArti Singh Review 06 January 2022 Pages: 285 - 294
Diacerein ameliorates induced polycystic ovary in female rats via modulation of inflammasome/caspase1/IL1β and Bax/Bcl2 pathways Marwa M. M. RefaieMaram El-HussienyWedad M. Abdelraheem Original Article 07 January 2022 Pages: 295 - 304
Pycnogenol ameliorates motor function and gene expressions of NF-ƙB and Nrf2 in a 6-hydroxydopamine-induced experimental model of Parkinson’s disease in male NMRI mice Farajollah JafariMahdi GoudarzvandJalal Solati Original Article 13 January 2022 Pages: 305 - 313
Resveratrol inhibits the expression of RYR2 and is a potential treatment for pancreatic cancer He JiangGuotai WangQingyong Ma Original Article 19 January 2022 Pages: 315 - 324
Asprosin, a novel therapeutic candidate for painful neuropathy: an experimental study in mice Sibel OzcanMuhammed Mirac KelestemurMete Ozcan Original Article 05 January 2022 Pages: 325 - 335
The effects of vitamin D on learning and memory of hypothyroid juvenile rats and brain tissue acetylcholinesterase activity and oxidative stress indicators Seyed Hamidreza Rastegar-MoghaddamMahmoud HosseiniAlireza Ebrahimzadeh Bideskan Original Article 04 January 2022 Pages: 337 - 351
Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats Meire S. S. GonçalvesEric Aian P. SilvaAndré S. Barreto Original Article 20 January 2022 Pages: 353 - 363
Effects of imidazoline agents in a rat conditioned place preference model of addiction V. ŞorodocG. Rusu-ZotaO. M. Manole Original Article Open access 08 January 2022 Pages: 365 - 376
Proposed hypothesis of GSK-3 β inhibition for stimulating Wnt/β-catenin signaling pathway which triggers liver regeneration process Chirag KhuranaOnkar Bedi Brief Communication 25 January 2022 Pages: 377 - 380